GE HealthCare Technologies Inc

Research GE HealthCare Technologies Inc (GEHC) on Bullrun: valuation model: 39.4% undervalued, market cap USD 29.59B, P/E 15.6, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGEHC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Valuation signal39.4% undervalued
• Market capUSD 29.59B
• P/E15.6
• Dividend yield0.2%
• Financial periodFY2025
• RevenueUSD 20.63B
• Revenue growth4.8%
• Net incomeUSD 2.08B
• Free cash flowUSD 1.51B
• Gross margin40.0%

Valuation Snapshot

Bullrun's latest valuation model marks GE HealthCare Technologies Inc as 39.4% undervalued; latest market cap is USD 29.59B; P/E is 15.6; dividend yield is 0.2%.

About GE HealthCare Technologies Inc

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

Frequently asked questions

Is GE HealthCare Technologies Inc overvalued or undervalued?

Bullrun's valuation model currently marks GE HealthCare Technologies Inc as 39.4% undervalued.

What is GE HealthCare Technologies Inc's market cap?

GE HealthCare Technologies Inc's market capitalization is USD 29.59B.

What is GE HealthCare Technologies Inc's P/E ratio?

GE HealthCare Technologies Inc's price-to-earnings (P/E) ratio is 15.6.

Does GE HealthCare Technologies Inc pay a dividend?

GE HealthCare Technologies Inc has a dividend yield of 0.2%.

What does GE HealthCare Technologies Inc do?

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.